Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells-Reference-Cited by-同舟云学术

Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells

Published:2020-04-20 Issue:6 Volume:22 Page:689-700
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Perry John M.,Tao Fang,Roy Anuradha,Lin Tara^ORCID,He Xi C.,Chen Shiyuan,Lu Xiuling,Nemechek Jacqelyn,Ruan Linhao,Yu Xiazhen,Dukes Debra,Moran Andrea,Pace Jennifer^ORCID,Schroeder Kealan,Zhao Meng^ORCID,Venkatraman Aparna,Qian Pengxu,Li Zhenrui,Hembree Mark,Paulson Ariel,He Zhiquan,Xu Dong^ORCID,Tran Thanh-Huyen,Deshmukh Prashant^ORCID,Nguyen Chi Thanh,Kasi Rajeswari M.,Ryan Robin,Broward Melinda,Ding Sheng,Guest Erin,August Keith^ORCID,Gamis Alan S.,Godwin Andrew,Sittampalam G. Sitta,Weir Scott J.,Li Linheng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/s41556-020-0507-y.pdf

Reference69 articles.

1. Kuttesch, J. F. Jr. Multidrug resistance in pediatric oncology. Invest. New Drugs 14, 55–67 (1996).

2. Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306–313 (2012).

3. Kreso, A. & Dick, J. E. Evolution of the cancer stem cell model. Cell Stem Cell 14, 275–291 (2014).

4. Dick, J. E. Stem cell concepts renew cancer research. Blood 112, 4793–4807 (2008).

5. Eppert, K. et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17, 1086–1093 (2011).

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic anticancer effects of omega-3 fatty acids (EPA/DHA) and anticancer drug Doxorubicin against human lung adenocarcinoma;Food Bioscience;2024-10

2. Epigenetic control of immunoevasion in cancer stem cells;Trends in Cancer;2024-09

3. Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma;Hematological Oncology;2024-08-29

4. Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment;ACS Nano;2024-08-22

5. Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis;Cell Communication and Signaling;2024-08-07